Emily Savas is an experienced litigator whose practice concentrates on pharmaceutical patent litigations and representation of generic drug manufacturers in Hatch-Waxman litigations. Emily is a registered patent agent and has experience negotiating sponsored research and clinical trial agreements.
Emily Savas is an experienced litigator whose practice concentrates on pharmaceutical patent litigations and representation of generic drug manufacturers in Hatch-Waxman litigations. Emily is a registered patent agent and has experience negotiating sponsored research and clinical trial agreements.
Pharmaceutical Patent Litigation
Emily represents pharmaceutical clients through all stages of litigation arising under the Hatch-Waxman amendments to the Federal Food, Drug, and Cosmetic Act. Emily’s experience includes preparing Paragraph IV notice letters, invalidity and non-infringement contentions, all aspects of fact and expert discovery, claim construction proceedings, dispositive motion practice, preliminary injunction proceedings and trial.
Emily leads patent litigations concerning infringement and invalidity of patent claims directed to pharmaceutical formulations, crystalline forms of drug substances, x-ray powder diffraction peak patterns, pharmacokinetics and methods of treating a wide variety of diseases, including multiple sclerosis, depression, psoriasis, Parkinson’s disease, chronic obstructive pulmonary disease, overactive bladder, attention deficit disorder and narcolepsy.
Contract Negotiation
Emily returned to Locke Lord in 2013 after serving as Contracts Officer at University of California, San Diego, where she provided guidance to University researchers and business officers on medical industry contract terms and conditions and clinical trial agreements. She has experience negotiating contract terms regarding intellectual property ownership, material transfers, confidentiality and publication, export control regulations, dispute resolution and indemnification.
Patent and Trademark Prosecution
Emily is a registered patent agent with an advanced degree in molecular biology, and has extensive experience in both trademark prosecution and litigation. She has represented business owners in a variety of trademark prosecutions and disputes, including ownership and infringement.
Emily is currently pro bono counsel for a nonprofit organization promoting access to essential medicines and is responsible for its international trademark portfolio.
Her representative experience includes: